Sat.Oct 29, 2022

article thumbnail

‘Science is just rocketing forward’: A Q&A with former NIH director Francis Collins

STAT News

LOS ANGELES — Francis Collins stepped down from his position as head of the National Institutes of Health at the end of last year — but he’s been staying plenty busy in 2022, serving until recently as acting science adviser to President Biden. STAT spoke with the trailblazing genetics researcher at this year’s annual meeting of the American Society of Human Genetics in Los Angeles.

Genetics 111
article thumbnail

A woman struggling with early-onset Alzheimer's got a moment of grace while shopping

NPR Health - Shots

Joe Arrigoni is the full-time caretaker for his wife Joani who has early onset Alzheimer's disease. A shopping trip on a particularly difficult day led to a moment of grace that Joe remembers.

110
110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New tentative approval for Amneal Pharms drug saxagliptin

Drug Patent Watch

[![saxagliptin structure]([link] Saxagliptin is the generic ingredient in one branded drug marketed by Astrazeneca Ab and is included in one NDA. There are two patents protecting this compound. There are…. The post New tentative approval for Amneal Pharms drug saxagliptin appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 40
article thumbnail

PHOTOS: If you had to leave home and could take only 1 keepsake, what would it be?

NPR Health - Shots

We asked refugees around the world to tell us of a memento they brought to connect them to their old life even as they embarked on a new and uncertain future.

104
104
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

New tentative approval for Teva Pharms drug eltrombopag

Drug Patent Watch

[![eltrombopag structure]([link] Eltrombopag is the generic ingredient in two branded drugs marketed by Novartis and is included in two NDAs. There are eight patents protecting this compound. There are four…. The post New tentative approval for Teva Pharms drug eltrombopag appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 40
article thumbnail

How the race gap in COVID-19 deaths flipped

NPR Health - Shots

NPR's Michel Martin speaks with reporter Akilah Johnson about the racial disparities in deaths from COVID-19.

85